Advanced in Chronic Kidney Disease

Kannaiyan S. Rabindranath

Pembroke Street, 3240, 
Hamilton, WKO, NZ 
Advanced in Chronic Kidney Disease
Pembroke Street, 3240, 
Hamilton, WKO, NZ 
OverviewLocationsClinical Research

Overview

Kannaiyan Rabindranath practices in Hamilton, New Zealand. Rabindranath is rated as an Advanced expert by MediFind in the treatment of Chronic Kidney Disease. Their top areas of expertise are Chronic Kidney Disease, End-Stage Renal Disease (ESRD), Low Blood Pressure, and Systemic Lupus Erythematosus (SLE).

Their clinical research consists of co-authoring 28 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 13 articles in the study of Chronic Kidney Disease.

Locations

Pembroke Street, 3240, Hamilton, WKO, New Zealand
Other Locations
London Rd, RG1 5AN, Reading, ENG, United Kingdom
London Rd, Reading, ENG, United Kingdom

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Phase 3, Randomized, Double-blind, Placebo-controlled Study of Atrasentan in Patients With IgA Nephropathy at Risk of Progressive Loss of Renal Function
A Phase 3, Randomized, Double-blind, Placebo-controlled Study of Atrasentan in Patients With IgA Nephropathy at Risk of Progressive Loss of Renal Function
Enrollment Status: Active_not_recruiting
Publish Date: October 15, 2024
Intervention Type: Drug
Study Drug: Atrasentan
Study Phase: Phase 3
A Phase 3 Randomized, Open-label (Sponsor-blind), Active-controlled, Parallel-group, Multi-center, Event Driven Study in Non-dialysis Subjects With Anemia Associated With Chronic Kidney Disease to Evaluate the Safety and Efficacy of Daprodustat Compared to Darbepoetin Alfa
A Phase 3 Randomized, Open-label (Sponsor-blind), Active-controlled, Parallel-group, Multi-center, Event Driven Study in Non-dialysis Subjects With Anemia Associated With Chronic Kidney Disease to Evaluate the Safety and Efficacy of Daprodustat Compared to Darbepoetin Alfa
Enrollment Status: Completed
Publish Date: April 02, 2024
Intervention Type: Drug
Study Drugs: Daprodustat, Darbepoetin Alpha
Study Phase: Phase 3
View 1 Less Clinical Trial

28 Total Publications

Treatment Patterns for End-Stage Kidney Failure in Patients With Systemic Lupus Erythematous.
Treatment Patterns for End-Stage Kidney Failure in Patients With Systemic Lupus Erythematous.
Journal: Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases
Published: May 16, 2024

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Rabindranath's expertise for a condition
ConditionClose
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile